Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""cefiderocol"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 651
Tytuł:
In vitro activity of antibiotics potentially effective against difficult-to-treat strains of Gram-negative rods: retrospective study.
Autorzy:
Kroneislová G; Department of Clinical Microbiology and ATB Centre, Institute of Medical Biochemistry and Laboratory Diagnostic, First Faculty of Medicine, Charles University and General University Hospital, Ke Karlovu 2, Prague, 12808, Czech Republic. .; Department of Biochemistry and Microbiology, Faculty of Food and Biochemical Technology, University of Chemistry and Technology, Prague, Czech Republic. .
Závora J; Department of Clinical Microbiology and ATB Centre, Institute of Medical Biochemistry and Laboratory Diagnostic, First Faculty of Medicine, Charles University and General University Hospital, Ke Karlovu 2, Prague, 12808, Czech Republic.; Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University-Olomouc, Olomouc, Czech Republic.
Adámková VG; Department of Plant Science, Cambridge University, Cambridge, UK.
Rýdlová A; Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK.
Adámková V; Department of Clinical Microbiology and ATB Centre, Institute of Medical Biochemistry and Laboratory Diagnostic, First Faculty of Medicine, Charles University and General University Hospital, Ke Karlovu 2, Prague, 12808, Czech Republic.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 09; Vol. 14 (1), pp. 8310. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Bacterial Agents*/pharmacology
Anti-Bacterial Agents*/therapeutic use
Cephalosporins*
Azabicyclo Compounds*
Humans ; Retrospective Studies ; Aztreonam ; Cefiderocol ; Gram-Negative Bacteria ; Colistin/pharmacology ; Microbial Sensitivity Tests ; Pseudomonas aeruginosa
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genotypic Evolution of Klebsiella pneumoniae Sequence Type 512 during Ceftazidime/Avibactam, Meropenem/Vaborbactam, and Cefiderocol Treatment, Italy.
Autorzy:
Arcari G
Cecilia F
Oliva A
Polani R
Raponi G
Sacco F
De Francesco A
Pugliese F
Carattoli A
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2023 Nov; Vol. 29 (11), pp. 2266-2274.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Ceftazidime*/pharmacology
Ceftazidime*/therapeutic use
Klebsiella Infections*/drug therapy
Klebsiella Infections*/epidemiology
Klebsiella Infections*/microbiology
Humans ; Meropenem/therapeutic use ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Klebsiella pneumoniae/genetics ; Bacterial Proteins/genetics ; beta-Lactamases/genetics ; Italy/epidemiology ; Microbial Sensitivity Tests ; Cefiderocol
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France.
Autorzy:
Jousset AB
Bouabdallah L
Birer A
Rosinski-Chupin I
Mariet JF
Oueslati S
Emeraud C
Girlich D
Glaser P
Naas T
Bonnin RA
Dortet L
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2023 Sep; Vol. 29 (9), pp. 1877-1881.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Escherichia coli*/genetics
Gammaproteobacteria*
France/epidemiology ; Europe ; Cephalosporins/pharmacology ; Cefiderocol
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Genomic analysis and antimicrobial activity of β-lactam/β-lactamase inhibitors and other agents against KPC-producing Klebsiella pneumoniae clinical isolates from Brazilian hospitals.
Autorzy:
Camargo CH; Centro de Bacteriologia, Instituto Adolfo Lutz, Avenida Dr. Arnaldo 351, 9º Andar, São Paulo, SP, 01246-902, Brazil. .; Faculdade de Medicina, Universidade de São Paulo, Avenida Dr. Arnaldo 455, São Paulo, 01246-902, Brazil. .
Yamada AY; Centro de Bacteriologia, Instituto Adolfo Lutz, Avenida Dr. Arnaldo 351, 9º Andar, São Paulo, SP, 01246-902, Brazil.; Faculdade de Medicina, Universidade de São Paulo, Avenida Dr. Arnaldo 455, São Paulo, 01246-902, Brazil.
de Souza AR; Centro de Bacteriologia, Instituto Adolfo Lutz, Avenida Dr. Arnaldo 351, 9º Andar, São Paulo, SP, 01246-902, Brazil.
Cunha MPV; Centro de Bacteriologia, Instituto Adolfo Lutz, Avenida Dr. Arnaldo 351, 9º Andar, São Paulo, SP, 01246-902, Brazil.
Ferraro PSP; Centro de Bacteriologia, Instituto Adolfo Lutz, Avenida Dr. Arnaldo 351, 9º Andar, São Paulo, SP, 01246-902, Brazil.
Sacchi CT; Laboratório Estratégico, Instituto Adolfo Lutz, Avenida Dr. Arnaldo 351, 10º Andar, São Paulo, 01246-902, Brazil.
Dos Santos MB; Laboratório Estratégico, Instituto Adolfo Lutz, Avenida Dr. Arnaldo 351, 10º Andar, São Paulo, 01246-902, Brazil.
Campos KR; Laboratório Estratégico, Instituto Adolfo Lutz, Avenida Dr. Arnaldo 351, 10º Andar, São Paulo, 01246-902, Brazil.
Tiba-Casas MR; Centro de Bacteriologia, Instituto Adolfo Lutz, Avenida Dr. Arnaldo 351, 9º Andar, São Paulo, SP, 01246-902, Brazil.
Freire MP; Faculdade de Medicina, Universidade de São Paulo, Avenida Dr. Arnaldo 455, São Paulo, 01246-902, Brazil.
Barretti P; Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Av. Prof. Montenegro, S/N, Botucatu, 18618-687, Brazil.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 05; Vol. 13 (1), pp. 14603. Date of Electronic Publication: 2023 Sep 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
beta-Lactamase Inhibitors*
Lactams*
Brazil ; Klebsiella pneumoniae ; Meropenem ; Genomics ; Carbapenems ; Cefiderocol
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Induced Heteroresistance in Carbapenem-Resistant Acinetobacter baumannii (CRAB) via Exposure to Human Pleural Fluid (HPF) and Its Impact on Cefiderocol Susceptibility.
Autorzy:
Mezcord V; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA 92831, USA.
Escalante J; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA 92831, USA.
Nishimura B; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA 92831, USA.
Traglia GM; Unidad de Genómica y Bioinformática, Departamento de Ciencias Biológicas, CENUR Litoral Norte, Universidad de la República, Salto 50000, Uruguay.
Sharma R; UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.
Vallé Q; UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.
Tuttobene MR; Área Biología Molecular, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario 2000, Argentina.; Instituto de Biología Molecular y Celular de Rosario (IBR, CONICET-UNR), Rosario 2000, Argentina.
Subils T; Instituto de Procesos Biotecnológicos y Químicos de Rosario (IPROBYQ, CONICET-UNR), Rosario 2000, Argentina.
Marin I; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA 92831, USA.
Pasteran F; National Regional Reference Laboratory for Antimicrobial Resistance (NRL), Servicio Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas, ANLIS Dr. Carlos G. Malbrán, Buenos Aires 1282, Argentina.
Actis LA; Department of Microbiology, Miami University, Oxford, OH 45056, USA.
Tolmasky ME; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA 92831, USA.
Bonomo RA; Research Service and GRECC, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH 44106, USA.; Departments of Medicine, Pharmacology, Molecular Biology and Microbiology, Biochemistry, Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.; CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, OH 44106, USA.
Rao G; UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.
Ramirez MS; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA 92831, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jul 21; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 21.
Typ publikacji:
Journal Article
MeSH Terms:
Acinetobacter baumannii*
Acinetobacter Infections*/drug therapy
Acinetobacter Infections*/microbiology
Humans ; Carbapenems/pharmacology ; Carbapenems/therapeutic use ; Microbial Sensitivity Tests ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; beta-Lactamases/genetics ; Iron/pharmacology ; Cefiderocol
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Performance evaluation of Bruker UMIC microdilution panel and disc diffusion to determine cefiderocol susceptibility in Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Achromobacter xylosoxidans and Burkolderia species
Autorzy:
Bianco, GabrieleAff1, Aff2, IDs10096024047457_cor1
Boattini, MatteoAff1, Aff2, Aff3
Comini, Sara
Gaibani, Paolo
Cavallo, RossanaAff1, Aff2
Costa, CristinaAff1, Aff2
Pokaż więcej
Źródło:
European Journal of Clinical Microbiology & Infectious Diseases. 43(3):559-566
Czasopismo naukowe
Szczegóły
Tytuł:
Elucidating the effect of iron acquisition systems in Klebsiella pneumoniae on susceptibility to the novel siderophore-cephalosporin cefiderocol.
Autorzy:
Daoud L; Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Al-Marzooq F; Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Moubareck CA; College of Natural and Health Sciences, Zayed University, Dubai, United Arab Emirates.
Ghazawi A; Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Collyns T; Tawam Hospital, Al Ain, United Arab Emirates.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Dec 29; Vol. 17 (12), pp. e0277946. Date of Electronic Publication: 2022 Dec 29 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Siderophores*/pharmacology
Klebsiella pneumoniae*
Cephalosporins/pharmacology ; Anti-Bacterial Agents/pharmacology ; Monobactams/pharmacology ; Iron/metabolism ; Microbial Sensitivity Tests ; Cefiderocol
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study
Autorzy:
Oliva, AlessandraAff1, IDs10096024048338_cor1
Liguori, L
Covino, S
Petrucci, F
Cogliati-Dezza, F
Curtolo, A
Savelloni, G
Comi, M
Sacco, F
Ceccarelli, G
Viscido, A
Alessandri, F
Raponi, G
Pugliese, F
Mastroianni, CM
Venditti, M
Pokaż więcej
Źródło:
European Journal of Clinical Microbiology & Infectious Diseases. :1-12
Czasopismo naukowe
Szczegóły
Tytuł:
Acinetobacter baumannii response to cefiderocol challenge in human urine.
Autorzy:
Nishimura B; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, 800 N State College Blvd, Fullerton, CA, 92831, USA.
Escalante J; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, 800 N State College Blvd, Fullerton, CA, 92831, USA.
Tuttobene MR; Área Biología Molecular, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario, Argentina.; Instituto de Biología Molecular y Celular de Rosario (IBR, CONICET-UNR), Rosario, Argentina.
Subils T; Instituto de Procesos Biotecnológicos y Químicos de Rosario (IPROBYQ, CONICET-UNR), Rosario, Argentina.
Mezcord V; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, 800 N State College Blvd, Fullerton, CA, 92831, USA.
Pimentel C; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, 800 N State College Blvd, Fullerton, CA, 92831, USA.
Georgeos N; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, 800 N State College Blvd, Fullerton, CA, 92831, USA.
Pasteran F; National Regional Reference Laboratory for Antimicrobial Resistance (NRL), Servicio Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas, ANLIS Dr. Carlos G. Malbrán, Buenos Aires, Argentina.
Rodriguez C; Centro de Referencia Para Lactobacilos (CERELA), CONICET, Tucumán, Argentina.
Sieira R; Instituto Leloir-IIBBA CONICET, Buenos Aires, Argentina.
Actis LA; Department of Microbiology, Miami University, Oxford, USA.
Tolmasky ME; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, 800 N State College Blvd, Fullerton, CA, 92831, USA.
Bonomo RA; Research Service and GRECC, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH, USA.; Departments of Medicine, Pharmacology, Molecular Biology and Microbiology, Biochemistry, Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, OH, USA.; CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, OH, USA.
Ramirez MS; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, 800 N State College Blvd, Fullerton, CA, 92831, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 May 24; Vol. 12 (1), pp. 8763. Date of Electronic Publication: 2022 May 24.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Acinetobacter baumannii*
Albumins/pharmacology ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Carbapenems/pharmacology ; Cephalosporins ; Humans ; Iron/pharmacology ; Microbial Sensitivity Tests ; Siderophores ; beta-Lactamases/genetics ; Cefiderocol
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trial.
Autorzy:
Wright H; Centre for Clinical Research, Faculty of Medicine, University of Queensland, Royal Brisbane and Women's Hospital Campus, Brisbane, Queensland, Australia. .; Department of Infectious Diseases, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia. .
Harris PNA; Centre for Clinical Research, Faculty of Medicine, University of Queensland, Royal Brisbane and Women's Hospital Campus, Brisbane, Queensland, Australia.; Department of Microbiology, Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
Chatfield MD; Centre for Clinical Research, Faculty of Medicine, University of Queensland, Royal Brisbane and Women's Hospital Campus, Brisbane, Queensland, Australia.
Lye D; Infectious diseases research and Training Office, National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Yong Loo School of Medicine, Singapore, Singapore.; Lee Chian School of Medicine, Singapore, Singapore.
Henderson A; Centre for Clinical Research, Faculty of Medicine, University of Queensland, Royal Brisbane and Women's Hospital Campus, Brisbane, Queensland, Australia.; Department of Infectious Diseases, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Harris-Brown T; Centre for Clinical Research, Faculty of Medicine, University of Queensland, Royal Brisbane and Women's Hospital Campus, Brisbane, Queensland, Australia.
Donaldson A; Centre for Clinical Research, Faculty of Medicine, University of Queensland, Royal Brisbane and Women's Hospital Campus, Brisbane, Queensland, Australia.
Paterson DL; Centre for Clinical Research, Faculty of Medicine, University of Queensland, Royal Brisbane and Women's Hospital Campus, Brisbane, Queensland, Australia.; Department of Infectious Diseases, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
Pokaż więcej
Źródło:
Trials [Trials] 2021 Dec 07; Vol. 22 (1), pp. 889. Date of Electronic Publication: 2021 Dec 07.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Gram-Negative Bacterial Infections*/diagnosis
Gram-Negative Bacterial Infections*/drug therapy
Sepsis*/drug therapy
Adult ; Anti-Bacterial Agents/therapeutic use ; Cephalosporins ; Delivery of Health Care ; Hospitals ; Humans ; Microbial Sensitivity Tests ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic ; Standard of Care ; Cefiderocol
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Carbapenem-Resistant Enterobacterales Infection After Massive Blast Injury: Use of Cefiderocol Based Combination Therapy.
Autorzy:
Carney BW; Brooke Army Medical Center, San Antonio, TX 78234, USA.
Rizzo JA; United States Army Institute of Surgical Research, San Antonio, TX 78234, USA.; Uniformed Services University of Health Sciences, Bethesda, MD 20814, USA.
Alderete JF; Brooke Army Medical Center, San Antonio, TX 78234, USA.
Cindass R; United States Army Institute of Surgical Research, San Antonio, TX 78234, USA.
Markelz AE; Brooke Army Medical Center, San Antonio, TX 78234, USA.
Cancio LC; Brooke Army Medical Center, San Antonio, TX 78234, USA.
Pokaż więcej
Źródło:
Military medicine [Mil Med] 2021 Nov 02; Vol. 186 (11-12), pp. 1241-1245.
Typ publikacji:
Journal Article
MeSH Terms:
Blast Injuries*/drug therapy
Carbapenems*/pharmacology
Carbapenems*/therapeutic use
Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Cephalosporins ; Escherichia coli ; Humans ; Male ; Microbial Sensitivity Tests ; Cefiderocol
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
In vitro activity of antibiotics potentially effective against difficult-to-treat strains of Gram-negative rods: retrospective study
Autorzy:
Gabriela Kroneislová
Jan Závora
Vanda Gabriela Adámková
Anna Rýdlová
Václava Adámková
Pokaż więcej
Temat:
Antimicrobial stewardship
Difficult-to-treat resistance
Aztreonam/avibactam
Cefiderocol
Ceftazidime/avibactam
Colistin
Medicine
Science
Źródło:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Opis pliku:
electronic resource
Relacje:
https://doaj.org/toc/2045-2322
Dostęp URL:
https://doaj.org/article/122d16db11de4ada974719c88cd74232  Link otwiera się w nowym oknie
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Reduce susceptibility to cefiderocol in gram negative bacteria in children: Is hope already lost before it’s even arrived?
Autorzy:
Chiara Russo
Alessio Mesini
Marcello Mariani
Elisa Tavella
Claudia Sette
Elisabetta Ugolotti
Claudia Bartalucci
Candida Palmero
Roberto Bandettini
Elio Castagnola
Pokaż więcej
Temat:
Cefiderocol
Carbapenem-resistance
Pediatric
Carbapenemases
Infectious and parasitic diseases
RC109-216
Public aspects of medicine
RA1-1270
Źródło:
Journal of Infection and Public Health, Vol 17, Iss 4, Pp 624-631 (2024)
Opis pliku:
electronic resource
Relacje:
http://www.sciencedirect.com/science/article/pii/S1876034124000327; https://doaj.org/toc/1876-0341
Dostęp URL:
https://doaj.org/article/b02e7f5085974f0ea0720240b0891843  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
In vitro activity of cefiderocol against Gram-negative pathogens isolated from people with cystic fibrosis and bronchiectasis
Autorzy:
Michael M Tunney
J Stuart Elborn
Chloe S McLaughlin
Christopher M Longshaw
Pokaż więcej
Temat:
Cefiderocol
Cystic fibrosis
Stenotrophomonas maltophilia
Achromobacter
Burkholderia cepacia complex
Microbiology
QR1-502
Źródło:
Journal of Global Antimicrobial Resistance, Vol 36, Iss , Pp 407-410 (2024)
Opis pliku:
electronic resource
Relacje:
http://www.sciencedirect.com/science/article/pii/S2213716524000298; https://doaj.org/toc/2213-7165
Dostęp URL:
https://doaj.org/article/775938bb17934ee3ab5b0511bb71c32e  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Recurrent neurosurgical site infection by extensively drug-resistant P. aeruginosa treated with cefiderocol: a case report and literature review.
Autorzy:
Bavaro DF; Clinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Bari, Italy.
Romanelli F; Microbiology and Virology Unit, University of Bari, University Hospital Policlinico, Bari, Italy.
Stolfa S; Microbiology and Virology Unit, University of Bari, University Hospital Policlinico, Bari, Italy.
Belati A; Clinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Bari, Italy.
Diella L; Clinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Bari, Italy.
Ronga L; Microbiology and Virology Unit, University of Bari, University Hospital Policlinico, Bari, Italy.
Fico C; Clinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Bari, Italy.
Monno L; Clinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Bari, Italy.
Mosca A; Microbiology and Virology Unit, University of Bari, University Hospital Policlinico, Bari, Italy.
Saracino A; Clinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Bari, Italy.
Pokaż więcej
Źródło:
Infectious diseases (London, England) [Infect Dis (Lond)] 2021 Mar; Vol. 53 (3), pp. 206-211. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji:
Case Reports; Journal Article; Review
MeSH Terms:
Pharmaceutical Preparations*
Pseudomonas aeruginosa*
Anti-Bacterial Agents/therapeutic use ; Cephalosporins/therapeutic use ; Gram-Negative Bacteria ; Humans ; Cefiderocol
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives.
Autorzy:
Terreni M; Department of Drug Science, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.
Taccani M; Department of Drug Science, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.
Pregnolato M; Department of Drug Science, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2021 May 02; Vol. 26 (9). Date of Electronic Publication: 2021 May 02.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Drug Design*
Drug Resistance, Multiple, Bacterial*
Anti-Bacterial Agents/*pharmacology
Animals ; Boronic Acids/pharmacology ; Cephalosporins/pharmacology ; Chemistry, Pharmaceutical/trends ; Clostridioides difficile ; Clostridium Infections/drug therapy ; Fluoroquinolones/pharmacology ; Gonorrhea/drug therapy ; Humans ; Meropenem/pharmacology ; Neisseria gonorrhoeae ; Nitroimidazoles/pharmacology ; Sisomicin/analogs & derivatives ; Sisomicin/pharmacology ; Tetracyclines/pharmacology ; beta-Lactamase Inhibitors/pharmacology ; Cefiderocol
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of antibiofilm activity of cefiderocol alone and in combination with imipenem against Pseudomonas aeruginosa
Autorzy:
Caterina Ferretti
Noemi Violeta Poma
Mariano Bernardo
Laura Rindi
Novella Cesta
Arianna Tavanti
Carlo Tascini
Mariagrazia Di Luca
Pokaż więcej
Temat:
Pseudomonas aeruginosa
Biofilm
Synergism
Cefiderocol
Imipenem
Microbiology
QR1-502
Źródło:
Journal of Global Antimicrobial Resistance, Vol 37, Iss , Pp 53-61 (2024)
Opis pliku:
electronic resource
Relacje:
http://www.sciencedirect.com/science/article/pii/S2213716524000250; https://doaj.org/toc/2213-7165
Dostęp URL:
https://doaj.org/article/1eb6102a3b90411f88567c2779f60038  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Extreme resistance to the novel siderophore-cephalosporin cefiderocol in an extensively drug-resistant Klebsiella pneumoniae strain causing fatal pneumonia with sepsis: genomic analysis and synergistic combinations for resistance reversal
Autorzy:
Daoud, Land
Allam, Mushal
Collyns, Timothy
Ghazawi, Akela
Saleem, Aqeel
Al-Marzooq, FarahAff1, IDs10096023046710_cor6
Pokaż więcej
Źródło:
European Journal of Clinical Microbiology & Infectious Diseases. :1-6
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 651

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies